Skip to Main Content

Paper Details

Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression.
Clin Epigenetics
25
2019
Author NameAffiliation
Ruth IsserlinUniversity of Toronto, College St
Theodorus H van der KwastUniversity of Toronto, 1 King's College Circle
Theodorus H van der KwastUniversity Health Network, University of Toronto
Alexandre R ZlottaLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital
Alexandre R ZlottaUniversity Health Network, University of Toronto
Gary D BaderUniversity of Toronto, College St
Neil E FleshnerUniversity Health Network, University of Toronto
Bharati BapatLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital
Bharati BapatUniversity of Toronto, 1 King's College Circle
Bharati BapatUniversity Health Network, University of Toronto
Bharati BapatUniversity Health Network, University of Toronto
  • 1 - 11

Datasets